387 related articles for article (PubMed ID: 27012987)
1. Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy.
Chalfin HJ; Liu JJ; Gandhi N; Feng Z; Johnson D; Netto GJ; Drake CG; Hahn NM; Schoenberg MP; Trock BJ; Scott AV; Frank SM; Bivalacqua TJ
Ann Surg Oncol; 2016 Aug; 23(8):2715-22. PubMed ID: 27012987
[TBL] [Abstract][Full Text] [Related]
2. Restrictive transfusion in radical cystectomy is safe.
Syan-Bhanvadia S; Drangsholt S; Shah S; Cai J; Miranda G; Djaladat H; Daneshmand S
Urol Oncol; 2017 Aug; 35(8):528.e15-528.e21. PubMed ID: 28476526
[TBL] [Abstract][Full Text] [Related]
3. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.
Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA
Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841
[TBL] [Abstract][Full Text] [Related]
4. Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy.
Diamantopoulos LN; Sekar RR; Holt SK; Khaki AR; Miller NJ; Gadzinski A; Nyame YA; Vakar-Lopez F; Tretiakova MS; Psutka SP; Gore JL; Lin DW; Schade GR; Hsieh AC; Lee JK; Yezefski T; Schweizer MT; Cheng HH; Yu EY; True LD; Montgomery RB; Grivas P; Wright JL
Urol Oncol; 2021 Aug; 39(8):496.e1-496.e8. PubMed ID: 33551249
[TBL] [Abstract][Full Text] [Related]
5. Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based study.
Siemens DR; Jaeger MT; Wei X; Vera-Badillo F; Booth CM
World J Urol; 2017 Sep; 35(9):1435-1442. PubMed ID: 28213861
[TBL] [Abstract][Full Text] [Related]
6. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A;
BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy.
Lee JS; Kim HS; Jeong CW; Kwak C; Kim HH; Ku JH
Korean J Urol; 2015 Apr; 56(4):295-304. PubMed ID: 25874043
[TBL] [Abstract][Full Text] [Related]
8. The impact of perioperative blood transfusion on survival following radical cystectomy for urothelial carcinoma.
Sadeghi N; Badalato GM; Hruby G; Kates M; McKiernan JM
Can J Urol; 2012 Oct; 19(5):6443-9. PubMed ID: 23040626
[TBL] [Abstract][Full Text] [Related]
9. Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Kluth LA; Xylinas E; Rieken M; El Ghouayel M; Sun M; Karakiewicz PI; Lotan Y; Chun FK; Boorjian SA; Lee RK; Briganti A; Rouprêt M; Fisch M; Scherr DS; Shariat SF
BJU Int; 2014 Mar; 113(3):393-8. PubMed ID: 24053618
[TBL] [Abstract][Full Text] [Related]
10. The role of neoadjuvant chemotherapy, lymph node dissection, and treatment delay in patients with muscle-invasive bladder cancer undergoing partial cystectomy.
Lenis AT; Fero KE; Ojeaburu L; Lec PM; Golla V; Brisbane W; Leapman MS; Chamie K
Urol Oncol; 2021 Aug; 39(8):496.e17-496.e24. PubMed ID: 33640225
[TBL] [Abstract][Full Text] [Related]
11. Impact of perioperative blood transfusions on oncologic outcomes after radical cystectomy: A systematic review and meta-analysis of comparative studies.
Uysal D; Egen L; Grilli M; Wessels F; Lenhart M; Michel MS; Kriegmair MC; Kowalewski KF
Surg Oncol; 2021 Sep; 38():101592. PubMed ID: 33979750
[TBL] [Abstract][Full Text] [Related]
12. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
Linder BJ; Frank I; Cheville JC; Tollefson MK; Thompson RH; Tarrell RF; Thapa P; Boorjian SA
Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
[TBL] [Abstract][Full Text] [Related]
13. A delay ≥8 weeks to neoadjuvant chemotherapy before radical cystectomy increases the risk of upstaging.
Audenet F; Sfakianos JP; Waingankar N; Ruel NH; Galsky MD; Yuh BE; Gin GE
Urol Oncol; 2019 Feb; 37(2):116-122. PubMed ID: 30509868
[TBL] [Abstract][Full Text] [Related]
14. The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group.
Gild P; Vetterlein MW; Seiler R; Necchi A; Hendricksen K; Mertens LS; Roghmann F; Landenberg NV; Gontero P; Cumberbatch M; Dobruch J; Seisen T; Grande P; D'Andrea D; Anract J; Comploj E; Pycha A; Saba K; Poyet C; van Rhijn BW; Noon AP; Roupret M; Shariat SF; Fisch M; Xylinas E; Rink M
Surg Oncol; 2020 Sep; 34():312-317. PubMed ID: 32891350
[TBL] [Abstract][Full Text] [Related]
15. Effect of perioperative blood transfusion on mortality for major urologic malignancies.
Soubra A; Zabell JR; Adejoro O; Konety BR
Clin Genitourin Cancer; 2015 Jun; 13(3):e173-81. PubMed ID: 25600760
[TBL] [Abstract][Full Text] [Related]
16. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality?
Abel EJ; Linder BJ; Bauman TM; Bauer RM; Thompson RH; Thapa P; Devon ON; Tarrell RF; Frank I; Jarrard DF; Downs TM; Boorjian SA
Eur Urol; 2014 Dec; 66(6):1139-47. PubMed ID: 25194909
[TBL] [Abstract][Full Text] [Related]
17. Perioperative Transfusion of Leukocyte-depleted Blood Products in Contemporary Radical Cystectomy Cohort Does Not Adversely Impact Short-term Survival.
Chipollini JJ; Tang DH; Patel SY; Garcia-Getting RE; Gilbert SM; Pow-Sang JM; Sexton WJ; Spiess PE; Poch MA
Urology; 2017 May; 103():142-148. PubMed ID: 28011275
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer.
Jiang DM; Jiang H; Chung PWM; Zlotta AR; Fleshner NE; Bristow RG; Berlin A; Kulkarni GS; Alimohamed NS; Lo G; Sridhar SS
Clin Genitourin Cancer; 2019 Feb; 17(1):38-45. PubMed ID: 30686350
[TBL] [Abstract][Full Text] [Related]
19. Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.
Raza SJ; Al-Daghmin A; Zhuo S; Mehboob Z; Wang K; Wilding G; Kauffman E; Guru KA
Eur Urol; 2014 Nov; 66(5):920-8. PubMed ID: 24768522
[TBL] [Abstract][Full Text] [Related]
20. Persistent muscle-invasive bladder cancer after neoadjuvant chemotherapy: an analysis of Surveillance, Epidemiology and End Results-Medicare data.
Lane G; Risk M; Fan Y; Krishna S; Konety B
BJU Int; 2019 May; 123(5):818-825. PubMed ID: 30126053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
